Posted by Michael Wonder on 09 Apr 2022
PBS listing of Paxlovid (nirmatrelvir and ritonavir)
9 April 2022 - Commencing 1 May 2022, Paxlovid (nirmatrelvir and ritonavir) will be listed on the PBS as a General Schedule, Authority Required (STREAMLINED) benefit for patients with mild to moderate COVID 19 who have a high risk for developing severe disease, reducing the need for admission to hospital.
Paxlovid was provisionally approved by the TGA on 18 January 2022, for the treatment of adults with COVID-19 who do not require initiation of oxygen and who are at increased risk of progression to hospitalisation or death.
